These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 32514535)

  • 1. Enhanced SMARCD1, a subunit of the SWI/SNF complex, promotes liver cancer growth through the mTOR pathway.
    Zhou Y; Xu Q; Tao L; Chen Y; Shu Y; Wu Z; Lu C; Shi Y; Bu H
    Clin Sci (Lond); 2020 Jun; 134(12):1457-1472. PubMed ID: 32514535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTORC1 Promotes ARID1A Degradation and Oncogenic Chromatin Remodeling in Hepatocellular Carcinoma.
    Zhang S; Zhou YF; Cao J; Burley SK; Wang HY; Zheng XFS
    Cancer Res; 2021 Nov; 81(22):5652-5665. PubMed ID: 34429326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MicroRNA-7 Compromises p53 Protein-dependent Apoptosis by Controlling the Expression of the Chromatin Remodeling Factor SMARCD1.
    Hong CF; Lin SY; Chou YT; Wu CW
    J Biol Chem; 2016 Jan; 291(4):1877-1889. PubMed ID: 26542803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Smarcd1 Inhibits the Malignant Phenotypes of Human Glioblastoma Cells via Crosstalk with Notch1.
    Zhu Y; Wang H; Fei M; Tang T; Niu W; Zhang L
    Mol Neurobiol; 2021 Apr; 58(4):1438-1452. PubMed ID: 33190170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SWI/SNF complex heterogeneity is related to polyphenotypic differentiation, prognosis, and immune response in rhabdoid tumors.
    Panwalkar P; Pratt D; Chung C; Dang D; Le P; Martinez D; Bayliss JM; Smith KS; Adam M; Potter S; Northcott PA; Mascarenhas L; Shows J; Pawel B; Margol A; Huang A; Judkins AR; Venneti S
    Neuro Oncol; 2020 Jun; 22(6):785-796. PubMed ID: 31912158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SWI/SNF subunit expression heterogeneity in human aplastic anemia stem/progenitors.
    Sinha S; Chatterjee SS; Biswas M; Nag A; Banerjee D; De R; Sengupta A
    Exp Hematol; 2018 Jun; 62():39-44.e2. PubMed ID: 29596882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
    Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
    Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional selectivity of recombinant mammalian SWI/SNF subunits.
    Kadam S; McAlpine GS; Phelan ML; Kingston RE; Jones KA; Emerson BM
    Genes Dev; 2000 Oct; 14(19):2441-51. PubMed ID: 11018012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SMARCA4 oncogenic potential via IRAK1 enhancer to activate Gankyrin and AKR1B10 in liver cancer.
    Kim SY; Shen Q; Son K; Kim HS; Yang HD; Na MJ; Shin E; Yu S; Kang K; You JS; Yu KR; Jeong SM; Lee EK; Ahn YM; Park WS; Nam SW
    Oncogene; 2021 Jul; 40(28):4652-4662. PubMed ID: 34140644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variant in SWI/SNF complexes influences hepatocellular carcinoma risk: a new clue for the contribution of chromatin remodeling in carcinogenesis.
    Zhong R; Liu L; Tian Y; Wang Y; Tian J; Zhu BB; Chen W; Qian JM; Zou L; Xiao M; Shen N; Yang H; Lou J; Qiu Q; Ke JT; Lu XH; Wang ZL; Song W; Zhang T; Li H; Wang L; Miao XP
    Sci Rep; 2014 Feb; 4():4147. PubMed ID: 24556940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the SWI/SNF chromatin remodeling complex in pancreatic ductal adenocarcinoma.
    Tsuda M; Fukuda A; Kawai M; Araki O; Seno H
    Cancer Sci; 2021 Feb; 112(2):490-497. PubMed ID: 33301642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BAFfling pathologies: Alterations of BAF complexes in cancer.
    Arnaud O; Le Loarer F; Tirode F
    Cancer Lett; 2018 Apr; 419():266-279. PubMed ID: 29374542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The SMARCD Family of SWI/SNF Accessory Proteins Is Involved in the Transcriptional Regulation of Androgen Receptor-Driven Genes and Plays a Role in Various Essential Processes of Prostate Cancer.
    Ertl IE; Brettner R; Kronabitter H; Mohr T; Derdak S; Jeitler M; Bilban M; Garstka N; Shariat SF
    Cells; 2022 Dec; 12(1):. PubMed ID: 36611918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and interaction of core subunits of BAF complexes and crystal study of the SMARCC1/SMARCE1 binary complex.
    Dong C; Zhang R; Xu L; Liu B; Chu X
    Biochem Biophys Res Commun; 2022 Apr; 599():9-16. PubMed ID: 35158202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The SWI/SNF chromatin remodeling assemblies BAF and PBAF differentially regulate cell cycle exit and cellular invasion in vivo.
    Smith JJ; Xiao Y; Parsan N; Medwig-Kinney TN; Martinez MAQ; Moore FEQ; Palmisano NJ; Kohrman AQ; Chandhok Delos Reyes M; Adikes RC; Liu S; Bracht SA; Zhang W; Wen K; Kratsios P; Matus DQ
    PLoS Genet; 2022 Jan; 18(1):e1009981. PubMed ID: 34982771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive assessment of the expression of the SWI/SNF complex defines two distinct prognostic subtypes of ovarian clear cell carcinoma.
    Abou-Taleb H; Yamaguchi K; Matsumura N; Murakami R; Nakai H; Higasa K; Amano Y; Abiko K; Yoshioka Y; Hamanishi J; Koshiyama M; Baba T; Yamada R; Matsuda F; Konishi I; Mandai M
    Oncotarget; 2016 Aug; 7(34):54758-54770. PubMed ID: 27340867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SWI/SNF-mutant cancers depend on catalytic and non-catalytic activity of EZH2.
    Kim KH; Kim W; Howard TP; Vazquez F; Tsherniak A; Wu JN; Wang W; Haswell JR; Walensky LD; Hahn WC; Orkin SH; Roberts CW
    Nat Med; 2015 Dec; 21(12):1491-6. PubMed ID: 26552009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BAF60A mediates interactions between the microphthalmia-associated transcription factor and the BRG1-containing SWI/SNF complex during melanocyte differentiation.
    Aras S; Saladi SV; Basuroy T; Marathe HG; Lorès P; de la Serna IL
    J Cell Physiol; 2019 Jul; 234(7):11780-11791. PubMed ID: 30515787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-223 potentially targets SWI/SNF complex protein SMARCD1 in atypical proliferative serous tumor and high-grade ovarian serous carcinoma.
    Arts FA; Keogh L; Smyth P; O'Toole S; Ta R; Gleeson N; O'Leary JJ; Flavin R; Sheils O
    Hum Pathol; 2017 Dec; 70():98-104. PubMed ID: 29079174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.